Gaslightwala Abizer 4/A
4/A · Akari Therapeutics Plc · Filed Feb 7, 2025
Insider Transaction Report
Form 4/AAmended
Gaslightwala Abizer
Director
Transactions
- Award
American Depository Shares representing Ordinary Shares
2025-01-10$1.22/sh+11,640$14,201→ 47,500 total
Footnotes (2)
- [F1]Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.
- [F2]On January 13, 2025, the Reporting Person previously reported the purchase of 11,439 ADS at purchase price of $1.22 per ADS. The Reporting Person actually acquired 11,640 ADS at a price raning from $1.22 per ADS to $1.28 per ADS. The Reporting Person also previously reported the total amount of securities beneficially owned following transaction as 35,860 and omitted the ADS acquired on January 10, 2025. The revised amount of securities beneficially owned following the transaction is 47,500 ADS.